This website will close on 30 April 2024. After this date, your content will not be accessible. Please contact for more information.

Proven innovation
Share innovation


By Bieke Van Gorp, FibriCheck Added 13th Oct, 2023 Updated 1st Nov, 2023

Our vision is to harness the power of device-agnostic solutions to enhance the quality of life and outcomes for patients. FibriCheck (CE (Class IIa) and MHRA certified) has gained recognition for its medical-certified smartphone application. Our application is designed to identify various cardiac arrhythmias, including Atrial Fibrillation, while also monitoring comorbidities such as blood pressure. To date, our solution has been embraced by over 600,000 users and has seamlessly integrated into the NHS patient journey (implementation in +40 settings). 



FibriCheck is a certified smartphone based medical device for the remote detection and management of people's heart health. Hardware free, it enables patients to self-monitor their heart rate, heart rhythm (including Atrial Fibrillation), symptoms/activity and log blood pressure readings as part of broader CVD cross conditions management and stroke prevention. FibriCheck is today adopted in over 40+ NHS centres.

The FibriCheck application is targeted to users with heart concerns, elderly and patients with atrial fibrillation (AF) and can be used as a standalone solution or integrated into other digital health platforms.FibriCheck has been extensively clinical validated in 60+ peer reviewed articles (accessible through the FibriCheck academy) and is successfully implemented across the patient journey.To illustrate some of our UK implementations:- Triage patients experiencing palpitations: Staffordshire and Stoke on Trent- Reducing Holter-device waiting lists by monitoring post-cryptogenic stroke patients remotely: BHRUT- Supporting virtual wards and alignment to usual care pathways: Chelsea and Westminster- Nurse-led virtual clinics to manage diagnosed AF patients: Mid and South Essex

Independent HE analysis (YHEC, Essex) has proven that FibriCheck is cost-effective or even cost-saving in multiple settings, including AF-management, post-cryptogenic stroke follow-up and AF detection. 

Patients consistently commend FibriCheck for its user-friendly interface, on-demand accessibility, and the reassurance it offers, while physicians appreciate the overnight implementation without costly pre-investments. 

Related Innovations